Evidence map›Paper›PMID 28258651›Full record

ArticleMolecular oncology2017

NMR metabolomics highlights sphingosine kinase-1 as a new molecular switch in the orchestration of aberrant metabolic phenotype in cancer cells.

Caterina Bernacchioni, Veronica Ghini, Francesca Cencetti, Lukasz Japtok, Chiara Donati, Paola Bruni, Paola Turano

Open access · goldAbstract read
In one paragraph

Article in Molecular oncology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. LncRNA MAFG-AS1 is involved in human cancer progression.European journal of medical research · 2023
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Cell communication and signaling : CCS · 2019
    Article
  15. Article
  16. High-Throughput Metabolomics by 1D NMR.Angewandte Chemie (International ed. in English) · 2019
    Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Caterina BernacchioniDepartment of Biomedical, Clinical and Experimental Sciences, University of Florence, Italy.
Veronica GhiniCERM and Department of Chemistry, University of Florence, Italy.
Francesca CencettiDepartment of Biomedical, Clinical and Experimental Sciences, University of Florence, Italy.
Lukasz JaptokDepartment of Toxicology, Faculty of Mathematics and Natural Science, Institute of Nutritional Science, University of Potsdam, Germany.
Chiara DonatiDepartment of Biomedical, Clinical and Experimental Sciences, University of Florence, Italy.
Paola BruniDepartment of Biomedical, Clinical and Experimental Sciences, University of Florence, Italy.
Paola TuranoCERM and Department of Chemistry, University of Florence, Italy.
University of Florence · ITUniversity of Potsdam · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Strong experimental evidence in animal and cellular models supports a pivotal role of sphingosine kinase-1 (SK1) in oncogenesis. In many human cancers, SK1 levels are upregulated and these increases are linked to poor prognosis in patients. Here, by employing untargeted NMR-based metabolomic profiling combined with functional validations, we report the crucial role of SK1 in the metabolic shift known as the Warburg effect in A2780 ovarian cancer cells. Indeed, expression of SK1 induced a high glycolytic rate, characterized by increased levels of lactate along with increased expression of the proton/monocarboxylate symporter MCT1, and decreased oxidative metabolism, associated with the accumulation of intermediates of the tricarboxylic acid cycle and reduction in CO

Indexed as

GlycolysisAdenocarcinomaAnimalsCarbon DioxideCell Cycle ProteinsCell Line, TumorFemaleGlucoseGlucose Transporter Type 3HumansLactic AcidMagnetic Resonance ImagingMetabolomicsMitochondriaOncogene ProteinsOvarian NeoplasmsCarbon DioxideCell Cycle ProteinsGlucoseGlucose Transporter Type 3Lactic AcidMCTS1 protein, humanOncogene ProteinsPhosphotransferases (Alcohol Group Acceptor)SLC2A3 protein, humanSphingosine KinaseTricarboxylic AcidsNMR-based metabolomicsovarian cancersphingosine kinase-1Warburg effect

Identifiers

PMID28258651
PMCPMC5527469
OpenAlexW2593038258

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.